Prescribing “Off-Label”: What Should a Physician Disclose?

Overview of attention for article published in The AMA Journal of Ethic, June 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#4 of 2,830)
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 92 news outlets
blogs: 4 blogs

twitter: 44 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 39 Mendeley

Summary News Blogs X Dimensions citations

So far, Altmetric has seen 140 news stories from 92 outlets.

Processo judicial nos EUA pode ameaçar confiança no Ozempic e similares

UOL, 02 Jul 2024

Os fabricantes dos mais populares medicamentos para perda de peso estão sendo desafiados na Justiça.

Lawsuit could challenge trust in Ozempic and other popular weight loss drugs

Health Reporter, 23 Jun 2024

Lawsuit could challenge trust in Ozempic and other popular weight loss drugs

MedicalXpress, 22 Jun 2024

The manufacturers of the most popular weight loss drugs are being challenged in court.

Lawsuit could challenge trust in Ozempic and other popular weight loss drugs

Phil's Stock World, 20 Jun 2024

The manufacturers of the most popular weight loss drugs are being challenged in court.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 136 additional news stories.